Loading...

Orphazyme

Chicago,  IL 
United States
https://www.orphazyme.com

Profile

Orphazyme is pioneering the Heat-Shock Protein response to develop innovative therapies for neurodegenerative orphan diseases. Arimoclomol, our lead candidate, is in development for four diseases: Niemann-Pick disease Type C (NPC), Gaucher Disease, Inclusion Body Myositis (IBM), and Amyotrophic Lateral Sclerosis (ALS). For more information, visit www.orphazyme.com